Regional anesthesia and muscle-wasting diseases in pediatrics: A focused educational review

Amr Elhamrawy1, Islam Elmitwalli1, Candice Burrier1,2

  • 1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, United States.

PubMed

Insights

Regional anesthesia offers a safer alternative to general anesthesia for pediatric patients with muscular dystrophies. This approach minimizes risks associated with anesthetic agents and opioids, crucial for managing respiratory and cardiac complications in these muscle-wasting diseases.

Area of Science:

  • Anesthesiology
  • Neurology
  • Pediatrics

Background:

  • Muscular dystrophies are genetic disorders causing progressive muscle degeneration and weakness.
  • These conditions affect skeletal, cardiac, and smooth muscles, frequently impacting respiratory function.
  • Perioperative respiratory failure is a significant risk in muscular dystrophy patients due to anesthetic agents and opioids.

Purpose of the Study:

  • To review and summarize the use of regional anesthesia techniques in pediatric patients with muscular dystrophies.
  • To explore regional anesthesia as an alternative or adjunct to general anesthesia.
  • To highlight strategies for optimizing perioperative care in this vulnerable population.

Main Methods:

  • Literature review of existing studies on regional anesthesia in pediatric muscular dystrophy patients.
  • Educational summary of anesthetic considerations and techniques.
  • Analysis of potential benefits and risks of regional anesthesia.

Main Results:

  • Regional anesthesia may mitigate the adverse hemodynamic and respiratory effects of general anesthesia and opioids.
  • Specific regional anesthetic techniques are discussed in the context of muscular dystrophy.
  • The review provides an educational framework for clinicians.

Conclusions:

  • Regional anesthesia presents a potentially safer perioperative management strategy for pediatric patients with muscular dystrophies.
  • Careful consideration of anesthetic choices is vital to prevent postoperative respiratory complications.
  • Further research may elucidate optimal regional anesthetic protocols for this patient group.

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
460
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
330
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
570
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
350